|
[1]
|
Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)
Journal of Alzheimer's Disease,
2023
DOI:10.3233/JAD-230555
|
|
|
|
|
[2]
|
Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline
Neurology and Therapy,
2020
DOI:10.1007/s40120-020-00215-2
|
|
|
|
|
[3]
|
Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study
Journal of Clinical Medicine,
2019
DOI:10.3390/jcm8111893
|
|
|
|
|
[4]
|
Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study
Journal of Clinical Medicine,
2019
DOI:10.3390/jcm8111893
|
|
|
|
|
[5]
|
Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses
PLOS ONE,
2017
DOI:10.1371/journal.pone.0170749
|
|
|
|
|
[6]
|
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Ageing Research Reviews,
2017
DOI:10.1016/j.arr.2017.03.002
|
|
|
|
|
[7]
|
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease
SAGE Open Medicine,
2015
DOI:10.1177/2050312115598250
|
|
|
|
|
[8]
|
Association of Apolipoprotein E Genetic Variation in Alzheimer’s Disease in Indian Population
American Journal of Alzheimer's Disease & Other Dementiasr,
2014
DOI:10.1177/1533317514531443
|
|
|
|